The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Adma Biologics Inc shares valued at $450,660 were sold by Grossman Adam S on Apr 15 ’25. At $21.46 per share, Grossman Adam S sold 21,000 shares. The insider’s holdings dropped to 2,055,850 shares worth approximately $43.58 million following the completion of this transaction.
Also, Grossman Adam S sold 21,000 shares, netting a total of over 397,320 in proceeds. Following the sale of shares at $18.92 each, the insider now holds 2,061,850 shares.
Before that, Grossman Adam S had added 84,000 shares to its account. In a trade valued at $1,571,640, the Director and Officer bought Adma Biologics Inc shares for $18.71 each.
Analysts at Mizuho started covering the stock with ‘”a Buy”‘ outlook in a report released in mid October. As of November 11, 2021, Raymond James has increased its “an Outperform” rating to a “Strong buy” for ADMA. Earlier on November 09, 2021, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for ADMA stock.
Analyzing ADMA Stock Performance
During the last five days, there has been a drop of approximately -8.90%. Over the course of the year, Adma Biologics Inc shares have jumped approximately 23.62%. Shares of the company reached a 52-week high of $25.67 on 04/28/25 and a 52-week low of $13.50 on 03/04/25. A 50-day SMA is recorded $19.95, while a 200-day SMA reached $18.12.
Support And Resistance Levels for Adma Biologics Inc (ADMA)
According to the 24-hour chart, there is a support level at 19.06, which, if violated, would cause prices to drop to 16.91. In the upper region, resistance lies at 23.04. The next price resistance is at 24.87. RSI (Relative Strength Index) is 47.96 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.06, which suggests the price will decrease in the coming days. Percent R is at 64.60%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
